{"filing":{"accession_number":"0001213900-26-079898","cik":"0002035992","ticker":"MCTA","company_name":"Charming Medical Ltd","form":"6-K","filing_date":"2026-07-21","report_date":null,"primary_document":"ea0298610-6k_charming.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/2035992/000121390026079898/ea0298610-6k_charming.htm"},"events":[{"id":19053,"run_id":17146,"accession_number":"0001213900-26-079898","anchor_item_number":null,"event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.92,"summary":"The 6-K discloses a series of voluntary corporate governance enhancements by Charming Medical's board, including: (1) a lock-up agreement by majority shareholder and CEO Ms. Kit Wong restricting share sales for one year; (2) the company's election to abandon foreign private issuer exemptions and comply fully with Nasdaq domestic governance standards; and (3) the irrevocable surrender and cancellation of all Class B Ordinary Shares (held by Ms. Wong), eliminating the dual-class voting structure and reducing her voting power from ~91.25% to ~68.19%. These measures materially affect shareholder governance rights and the company's capital structure and listing compliance posture.","company_name":"Charming Medical Ltd","ticker":"MCTA","filing_date":"2026-07-21","form":"6-K","submitted_at":null,"items":null}],"classifications":[{"id":18045,"accession_number":"0001213900-26-079898","item_number":null,"item_title":null,"event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The 6-K discloses a series of voluntary corporate governance enhancements by Charming Medical's board, including: (1) a lock-up agreement by majority shareholder and CEO Ms. Kit Wong restricting share sales for one year; (2) the company's election to abandon foreign private issuer exemptions and comply fully with Nasdaq domestic governance standards; and (3) the irrevocable surrender and cancellation of all Class B Ordinary Shares (held by Ms. Wong), eliminating the dual-class voting structure and reducing her voting power from ~91.25% to ~68.19%. These measures materially affect shareholder governance rights and the company's capital structure and listing compliance posture.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-21T16:31:39.614686+00:00","company_name":"Charming Medical Ltd","ticker":"MCTA","filing_date":"2026-07-21"}]}